Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager

Arcticzymes Technologies ASA

OSE:AZT

Watchlist

Dividends

Price: 13.16 NOK -2.52%

Market Cap: 684.8m NOK

Have any thoughts about
Arcticzymes Technologies ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 13.16 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

AZT Alert

Arcticzymes Technologies ASA

13.16

-0.34 (-2.52%)

52 Week Range	13.1 42.75
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Arcticzymes Technologies ASA

What unique competitive advantages
does Arcticzymes Technologies ASA hold over its rivals?

What risks and challenges
does Arcticzymes Technologies ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Arcticzymes Technologies ASA.

What unique competitive advantages
does Arcticzymes Technologies ASA hold over its rivals?

What risks and challenges
does Arcticzymes Technologies ASA face in the near future?

Summarize the latest earnings call
of Arcticzymes Technologies ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Arcticzymes Technologies ASA.

Provide P/S
for Arcticzymes Technologies ASA.

Provide P/E
for Arcticzymes Technologies ASA.

Provide P/OCF
for Arcticzymes Technologies ASA.

Provide P/FCFE
for Arcticzymes Technologies ASA.

Provide P/B
for Arcticzymes Technologies ASA.

Provide EV/S
for Arcticzymes Technologies ASA.

Provide EV/GP
for Arcticzymes Technologies ASA.

Provide EV/EBITDA
for Arcticzymes Technologies ASA.

Provide EV/EBIT
for Arcticzymes Technologies ASA.

Provide EV/OCF
for Arcticzymes Technologies ASA.

Provide EV/FCFF
for Arcticzymes Technologies ASA.

Provide EV/IC
for Arcticzymes Technologies ASA.

Show me price targets
for Arcticzymes Technologies ASA made by professional analysts.

What are the Revenue projections
for Arcticzymes Technologies ASA?

How accurate were the past Revenue estimates
for Arcticzymes Technologies ASA?

What are the Net Income projections
for Arcticzymes Technologies ASA?

How accurate were the past Net Income estimates
for Arcticzymes Technologies ASA?

What are the EPS projections
for Arcticzymes Technologies ASA?

How accurate were the past EPS estimates
for Arcticzymes Technologies ASA?

What are the EBIT projections
for Arcticzymes Technologies ASA?

How accurate were the past EBIT estimates
for Arcticzymes Technologies ASA?

Compare the revenue forecasts
for Arcticzymes Technologies ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Arcticzymes Technologies ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Arcticzymes Technologies ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Arcticzymes Technologies ASA compared to its peers.

Compare the P/E ratios
of Arcticzymes Technologies ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Arcticzymes Technologies ASA with its peers.

Analyze the financial leverage
of Arcticzymes Technologies ASA compared to its main competitors.

Show all profitability ratios
for Arcticzymes Technologies ASA.

Provide ROE
for Arcticzymes Technologies ASA.

Provide ROA
for Arcticzymes Technologies ASA.

Provide ROIC
for Arcticzymes Technologies ASA.

Provide ROCE
for Arcticzymes Technologies ASA.

Provide Gross Margin
for Arcticzymes Technologies ASA.

Provide Operating Margin
for Arcticzymes Technologies ASA.

Provide Net Margin
for Arcticzymes Technologies ASA.

Provide FCF Margin
for Arcticzymes Technologies ASA.

Show all solvency ratios
for Arcticzymes Technologies ASA.

Provide D/E Ratio
for Arcticzymes Technologies ASA.

Provide D/A Ratio
for Arcticzymes Technologies ASA.

Provide Interest Coverage Ratio
for Arcticzymes Technologies ASA.

Provide Altman Z-Score Ratio
for Arcticzymes Technologies ASA.

Provide Quick Ratio
for Arcticzymes Technologies ASA.

Provide Current Ratio
for Arcticzymes Technologies ASA.

Provide Cash Ratio
for Arcticzymes Technologies ASA.

What is the historical Revenue growth
over the last 5 years for Arcticzymes Technologies ASA?

What is the historical Net Income growth
over the last 5 years for Arcticzymes Technologies ASA?

What is the current Free Cash Flow
of Arcticzymes Technologies ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Arcticzymes Technologies ASA.

EV/EBITDA
Enterprise Value to EBITDA

116.7

Current

68.9

Median

4.2

Industry

Higher than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

116.7

Enterprise Value

524.7m NOK

EBITDA

4.5m NOK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
NO		Arcticzymes Technologies ASA OSE:AZT	689.5m NOK	116.7
FR		Pharnext SCA OTC:PNEXF	6T USD	-218 147.8
US		Abbvie Inc NYSE:ABBV	320.1B USD	15.6
US		Amgen Inc NASDAQ:AMGN	150.5B USD	16.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	120.4B USD	25
US		Gilead Sciences Inc NASDAQ:GILD	113.8B USD	10
US	E	Epizyme Inc F:EPE	94.1B EUR	-517.9
AU		CSL Ltd ASX:CSL	135.7B AUD	20.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.9B USD	16.3
US	S	Seagen Inc F:SGT	39.3B EUR	-59.2
NL		argenx SE XBRU:ARGX	35B EUR	-106.8

				EBITDA Growth
NO		Arcticzymes Technologies ASA OSE:AZT	Average EV/EBITDA: 31.5 116.7	14%
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -218 147.8	N/A
US		Abbvie Inc NYSE:ABBV	15.6	29%
US		Amgen Inc NASDAQ:AMGN	16.8	62%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	25	43%
US		Gilead Sciences Inc NASDAQ:GILD	10	16%
US	E	Epizyme Inc F:EPE	Negative Multiple: -517.9	N/A
AU		CSL Ltd ASX:CSL	20.5	42%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	16.3	35%
US	S	Seagen Inc F:SGT	Negative Multiple: -59.2	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -106.8	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

173.2

2-Years Forward

EV/EBITDA

49.5

3-Years Forward

EV/EBITDA

20.8

Arcticzymes Technologies ASA
OSE:AZT

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Arcticzymes Technologies ASA OSE:AZT

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Arcticzymes Technologies ASA
OSE:AZT

EV/EBITDA
Enterprise Value to EBITDA